FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| ProRx | 118230111 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 150 mg/5 mL; .1 mg/5 mL; 10 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| ProRx | 118230111 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 150 mg/5 mL; .05 mg/5 mL; 5 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| Qualgen LLC | 034474862 | 69761-102 | 69761-102-01 | Testosterone | 100 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-203 | 69761-203-01 | Testosterone | 200 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-252 | 69761-252-01 | Testosterone | 25 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-372 | 69761-372-01 | Testosterone | 37.5 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-122 | 69761-122-01 | Testosterone | 12.5 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-503 | 69761-503-01 | Testosterone | 50 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-873 | 69761-873-01 | Testosterone | 87.5 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-103 | 69761-103-01 | Testosterone | 100 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-872 | 69761-872-01 | Testosterone | 87.5 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-202 | 69761-202-01 | Testosterone | 200 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-502 | 69761-502-01 | Testosterone | 50 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-181 | 69761-181-01 | Estradiol | 18 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-061 | 69761-061-01 | Estradiol | 6 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-251 | 69761-251-01 | Estradiol | 25 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-121 | 69761-121-01 | Estradiol | 12.5 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-101 | 69761-101-01 | Estradiol | 10 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-151 | 69761-151-01 | Estradiol | 15 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-201 | 69761-201-01 | Estradiol | 20 mg | 2025-2 | valid | 2026-08-12 | |
| Qualgen LLC | 034474862 | 69761-212 | 69761-212-01 | Anastrozole; Testosterone | 20 mg; 200 mg | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Phenylephrine | 40 mg/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Phenylephrine | 20 mg/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Phenylephrine | 50 mg/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Phenylephrine | 1 mg/10 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Phenylephrine | 15000 mg/1500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Phenylephrine Hydrochloride | 300 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 50 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-486 | 70092-486-46 | Phenylephrine Hydrochloride | 800 ug/10 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-170 | 70092-170-05 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Phenylephrine Hydrochloride | 120 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 1000 ug/10 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Phenylephrine Hydrochloride | 240 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Potassium Chloride; Magnesium Sulfate Heptahydrate; Lidocaine | 1.94 g/1052.8 mL; 2 g/1052.8 mL; .13 g/1052.8 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Rocuronium Bromide | 30 g/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Rocuronium Bromide | 100 mg/10 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Rocuronium Bromide | 30 g/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-333 | 70092-333-75 | Ropivacaine Hydrochloride | 200 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-335 | 70092-335-76 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Ropivacaine Hydrochloride | 6000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-588 | 70092-588-38 | Ropivacaine Hydrochloride | 1000 mg/500 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-657 | 70092-657-76 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-440 | 70092-440-76 | Ropivacaine Hydrochloride; Fentanyl Citrate | 400 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Succinylcholine | 60000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Succinylcholine | 100 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 |